Longitudinal Study of Multi-Analyte Profile for Dyslipidemia

• Status: Unknown status
• Trial end date: 2012-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The primary objective of this study is to determine any changes in cardiovascular risk among individuals receiving a statin by assessing their multi-analyte profile.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: MaiHealth Inc
• Treatments: Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pravastatin

Criteria

Inclusion Criteria:

• Sign and Date IRB approved consent form

• Be between 30-65 years of age as of date of consent

• Have a total cholesterol value of 200-300 (units)

• Have an LDL cholesterol value of > 100 (units)

• Able to speak and understand English

• Willing and able to participate for the 6 months required by the study

• Willing and able to provide fasting blood specimens

• Women of child-bearing potential must have a negative pregnancy test at screening

• Medically (appropriate) eligible to take the statin as determined by PI

Exclusion Criteria:

• Have a body Mass Index (BMI) > or = 35

• Pregnant (or planning to become pregnant during the course of the study)

• Currently taking a statin or discontinued taking a statin within 9 months of the date of screening